Magic mirrors to AI dolls, five health tech innovations to watch out for
CES event showcased cutting-edge health tech innovations, including smart diapers, AI-powered glasses, and a walking ...
Restless legs syndrome is incurable. Here's how to manage the symptoms
Restless legs syndrome (RLS), also known as Willis-Ekbom Disease, is a neurological condition that affects about 7% of people ...
Alzheimer's: 'Revolutionary' Discovery May Pave Way To Prevention
The finding may open a whole new world in the study of Alzheimer's disease, said biophysicist Aneta Stefanovska.
Quince Therapeutics Receives Notice of Allowance Covering Innovative Method of Use for Lead Indication Ataxia-Telangiectasia
Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s ...
Healio13h
IV edaravone may slow disease-progression milestones in ALS
Treatment with IV edaravone for ALS was linked to a slowing of disease-progression milestones compared with no IV edaravone ...
Local couple’s son battles rare neurological disorder, makes progress with treatment
A local couple, both firefighters, faced a personal crisis when their two-year-old son, Bentley, was diagnosed with ...
Healio8h
FDA approves Onapgo for motor fluctuations in adults with Parkinson’s disease
The FDA has approved Onapgo, the first subcutaneous apomorphine device to treat motor fluctuations in adults with Parkinson’s disease, according to the manufacturer.In a press release, Supernus ...
The Lancet6h
First phase 3 trial of GLP-1 receptor agonist for neurodegeneration
The discovery and development of GLP-1 receptor agonists for type 2 diabetes and obesity is a bench-to-bedside success story.1 Multiple GLP-1 receptor agonists are now in clinical use, such as ...